Trial Profile
A Phase 2, 28-Day Parallel-Group, Double-Masked, Dose Finding Study Comparing The Safety And Efficacy Of PF-03187207 To Latanoprost In Patients With Primary Open Angle Glaucoma Or Ocular Hypertension.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Sep 2020
Price :
$35
*
At a glance
- Drugs Latanoprostene bunod (Primary) ; Latanoprost
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Bausch & Lomb
- 18 Dec 2013 New trial record